Tadala Black: Advanced Erectile Dysfunction Therapy for Sustained Performance
| Product dosage: 80mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.45 | $73.52 (0%) | 🛒 Add to cart |
| 60 | $1.98 | $147.05 $118.85 (19%) | 🛒 Add to cart |
| 90 | $1.85 | $220.57 $166.18 (25%) | 🛒 Add to cart |
| 120 | $1.78 | $294.10 $213.52 (27%) | 🛒 Add to cart |
| 180 | $1.70 | $441.14 $305.17 (31%) | 🛒 Add to cart |
| 270 | $1.65 | $661.71 $444.16 (33%) | 🛒 Add to cart |
| 360 | $1.62
Best per pill | $882.29 $584.16 (34%) | 🛒 Add to cart |
Similar products
Tadala Black represents a significant advancement in the pharmacological management of erectile dysfunction, offering a reliable and potent therapeutic option for adult males. This medication, containing Tadalafil as its active pharmaceutical ingredient, is formulated to provide extended duration of efficacy while maintaining a favorable safety profile. Clinical evidence supports its mechanism of action as a phosphodiesterase type 5 (PDE5) inhibitor, facilitating increased blood flow to the corpus cavernosum upon sexual stimulation. Proper medical evaluation and prescription are mandatory before initiation of therapy to ensure appropriate patient selection and dosing.
Features
- Active ingredient: Tadalafil 20mg per tablet
- Pharmacological class: Selective phosphodiesterase type 5 (PDE5) inhibitor
- Duration of action: Up to 36 hours post-administration
- Onset of action: Typically within 30-120 minutes
- Bioavailability: Approximately 36% following oral administration
- Protein binding: 94% primarily to albumin and α1-acid glycoprotein
- Metabolism: Primarily hepatic via CYP3A4 isoenzyme
- Excretion: Predominantly fecal (approximately 61% of dose) and urinary (approximately 36% of dose)
- Manufacturer compliance: Current Good Manufacturing Practice (cGMP) certified production facilities
Benefits
- Provides extended therapeutic window allowing for spontaneous sexual activity
- Enhances erectile function through nitric oxide-mediated vasodilation
- Demonstrates consistent efficacy across various etiologies of erectile dysfunction
- Maintains effectiveness regardless of food intake (non-enteric coated formulation)
- Offers simplified dosing regimen compared to shorter-acting alternatives
- Shows improvement in erectile function scores in clinical validation studies
Common use
Tadala Black is indicated for the treatment of erectile dysfunction in adult males. The medication requires sexual stimulation for efficacy and does not automatically induce erection. Clinical studies demonstrate effectiveness across various patient subgroups, including those with diabetes mellitus, hypertension, and benign prostatic hyperplasia. The extended duration of action provides flexibility in timing sexual activity without the need for precise scheduling around medication administration.
Dosage and direction
The recommended starting dose is 10mg taken orally at least 30 minutes before anticipated sexual activity. Based on efficacy and tolerability, the dose may be increased to 20mg or decreased to 5mg. Maximum recommended dosing frequency is once per 24-hour period. Administration with or without food is acceptable, though high-fat meals may delay time to maximum concentration by approximately 1 hour. Tablet should be swallowed whole with a full glass of water; do not crush, chew, or split tablets.
Precautions
Cardiovascular status should be assessed prior to initiating therapy. Sexual activity presents potential cardiac risk for patients with pre-existing cardiovascular disease. Use with caution in patients with anatomical deformation of the penis or conditions that may predispose to priapism. Temporary decreases in systolic and diastolic blood pressure may occur. Visual disturbances have been reported; discontinue use if sudden vision loss occurs. Hearing changes or sudden decrease/loss of hearing have been reported. Avoid concurrent use with other erectile dysfunction treatments.
Contraindications
Concomitant administration with organic nitrates in any form. Concurrent use with guanylate cyclase stimulators. History of hypersensitivity to Tadalafil or any component of the formulation. Patients with severe hepatic impairment (Child-Pugh Class C). Unstable angina or recent myocardial infarction. Uncontrolled hypertension or hypotension. History of non-arteritic anterior ischemic optic neuropathy. Severe renal impairment requiring dialysis.
Possible side effects
Common adverse reactions (≥2%) include headache (15%), dyspepsia (13%), back pain (6%), myalgia (5%), nasal congestion (4%), flushing (3%), and limb pain (3%). Less frequent reactions include dizziness, visual disturbances, and gastroesophageal reflux. Serious but rare adverse events include priapism, sudden hearing loss, and cardiovascular events. Most adverse reactions are mild to moderate in severity and transient in nature.
Drug interaction
Strong CYP3A4 inhibitors (ketoconazole, ritonavir) increase Tadalafil exposure—maximum dose 10mg every 72 hours. Moderate CYP3A4 inhibitors (erythromycin, aprepitant) may increase exposure—consider 10mg starting dose. Concomitant alpha-blockers may enhance blood pressure-lowering effects—initiate at lowest dose. Nitrates are absolutely contraindicated. Alcohol may increase blood pressure-lowering effects and orthostatic symptoms. Antihypertensives may have additive hypotensive effects.
Missed dose
Tadala Black is taken on an as-needed basis rather than scheduled dosing. If a dose is missed, take when remembered if sufficient time remains before sexual activity. Do not double doses or take more than one dose within 24 hours. The extended duration of action provides flexibility in timing, making strict scheduling unnecessary.
Overdose
Symptoms may include severe headache, visual disturbances, syncope, prolonged erection, and hypotension. Standard supportive measures should be implemented as appropriate. Hemodialysis contributes negligibly to Tadalafil elimination. Management of priapism requires immediate urological intervention to avoid penile tissue damage and permanent loss of potency. Hypotension should be managed with cardiovascular support including fluid administration.
Storage
Store at controlled room temperature 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C and 30°C (59°F and 86°F). Keep container tightly closed and protect from moisture and light. Keep out of reach of children and pets. Do not use after expiration date printed on packaging. Properly discard any unused medication through medication take-back programs.
Disclaimer
This information does not replace professional medical advice. Consult a healthcare provider before starting any new medication. Not for use by women, children, or individuals without erectile dysfunction. This product requires a valid prescription from a licensed healthcare professional. Individual results may vary based on physiological factors and underlying health conditions.
Reviews
Clinical trials demonstrate 81% improvement in erectile function scores compared to placebo. Patient satisfaction surveys indicate 76% of users report improved ability to achieve and maintain erection suitable for sexual activity. Real-world evidence supports maintained efficacy with long-term use in appropriate patient populations. Healthcare providers report favorable benefit-risk profile when used according to prescribing guidelines.